Patent · US Active

MND promoter chimeric antigen receptors

US10774343B2 · kind B2 · utility

18Cited by
33References
11Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 24, 2015
Grant dateSep 15, 2020
Priority date—
Expiry dateApr 24, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2740/15043
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Vector compositions comprising a myeloproliferative sarcoma virus enhancer, negative control region deleted, dl587rev primer-binding site substituted (MND) promoter operably linked to a chimeric antigen receptor (CAR) are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.